Troponin
(T)

Sample type:

• Plasma (lithium-heparin), frozen.

Uses:

• Immunoassay for the in vitro quantitative determination of cardiac troponin T (cTnT) in lithium heparin plasma. The immunoassay is intended to aid in the diagnosis of myocardial infarction.

Precautions:

• It is recommended to ask all patients who may be indicated for this test about biotin supplementation.

• Patients should be cautioned to stop biotin consumption at least 72 hours prior to the collection of a sample.

Interfering Factors:

• This test may exhibit interference when sample is collected from a person who is consuming a supplement with a high dose of biotin.

Pre analytical errors:

• Wrong patient identification while collection.

• Error in listing the prescribed tests.

• Delay in performing test.

• Patient’s not properly prepared for the test.

Corrective action:

• Correct patient identification while collection.

• Prescribe tests in good listing.

• Make the tests in time.

• Prepare the patient properly for the test.

Post analytical errors:

• Failure in reporting.

• Erroneous validation of analytical data.

• Improper data entry.

Corrective action:

• Make agood report.

• All analytical data should be available.

• Proper data entry.

Reference range:

• 0–0.04 ng/ml